Our research therefore aimed to determine whether chronically hyperglycemic patients are more likely to be diagnosed with a higher-grade meningioma and to determine the possible interconnectedness between the patients’ glycated hemoglobin (HbA1c), BMI, age and the Ki67 reactivity of the tumor, as a marker of cellular proliferation. The gene discussed is MKI67; the disease is meningioma.